Kasia Nej Wołosiak, Ph.D.
About Kasia Nej Wołosiak, Ph.D.
Kasia Nej Wołosiak, Ph.D., is a Medical Science Manager at Mirati Therapeutics, with extensive experience in oncology and a strong background in medical biology and cancer genetics. She has held various roles in medical science across multiple organizations, contributing to clinical development and collaboration with oncology institutions in Europe.
Work at Mirati Therapeutics
Kasia Nej Wołosiak, Ph.D., currently holds the position of Medical Science Manager at Mirati Therapeutics, a role she has occupied since 2022. In this capacity, she leverages her extensive background in oncology and medical science to drive initiatives that support the company's research and development efforts. Her responsibilities include collaborating with various stakeholders and managing relationships with Key Opinion Leaders in the oncology field.
Previous Experience in Oncology
Prior to her current role, Wołosiak worked at several notable organizations in the oncology sector. She served as Medical Science Liaison at Halozyme Therapeutics, Inc. from 2016 to 2020, and at Turning Point Therapeutics from 2020 to 2022. Additionally, she held the position of Medical Science Lead at SOTIO from 2014 to 2016. Her experience spans various aspects of clinical development and medical science, particularly in Europe.
Education and Expertise
Kasia Nej Wołosiak holds a Ph.D. in Medical Biology/Cancer Genetics from Pomeranian Medical University, which she completed from 2005 to 2008. She also earned an M.Sc. in Molecular Biology from the University of Szczecin between 1996 and 2001. Furthermore, she has a background in Economics, having received her M.Sc. from the Faculty of Economics and Organization of Food Economy at the University of Agriculture from 2001 to 2003. Her educational foundation supports her expertise in oncology, particularly in lung cancer and gastrointestinal cancers.
Engagement with Key Opinion Leaders
Wołosiak has developed a unique network of Key Opinion Leaders across multiple European countries, including Poland, Italy, and Germany. She has high-level experience in managing these relationships, which includes organizing advisory boards and participating in round table meetings. Her engagement extends to major oncology congresses such as ASCO and ESMO, where she collaborates with leading experts in the field.
Involvement in Research and Development
Kasia Nej Wołosiak actively participates in the Investigator Sponsored Trials Research Platform and Non-Clinical Research Program. Her focus is on identifying new research opportunities and advisory partnerships within the oncology landscape. Additionally, she serves as an expert and reviewer for The National Centre for Research and Development, evaluating scientific projects submitted for funding.